Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evamitra is an Ayurvedic proprietary medicine formulated as an oral syrup, developed and manufactured by Navil Laboratories. It is designed to support women's reproductive health from menarche to menopause, specifically targeting hormonal disturbances, menstrual bleeding disorders, painful menstruation (dysmenorrhea), and premenstrual syndrome (PMS). The formulation is a multi-herb mixture containing traditional Ayurvedic ingredients such as Ashoka, Lodhra, Shatavari, Gokhru, Dashmool, Kantakari, Anantamul, Nirgundi, Nagarmoth, Dhataki pushpa, Manjishtha, Guduchi, Punarnava, Triphala, Kumari, Shilajit, Ashwagandha, Shankhpushpi, Brahmi, Mandur, and Ulatkambal. These components work synergistically to regulate menstrual cycles, reduce hormonal fluctuations, alleviate uterine muscle spasms, and provide anti-inflammatory and uterine-tonic benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Evamitra.